4//SEC Filing
CoLucid Pharmaceuticals, Inc. 4
Accession 0000911916-15-000152
CIK 0001348649operating
Filed
May 6, 8:00 PM ET
Accepted
May 7, 12:33 PM ET
Size
5.5 KB
Accession
0000911916-15-000152
Insider Transaction Report
Form 4
Dallas Matthew D
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-05-05+180,254→ 180,254 totalExercise: $10.00Exp: 2025-05-05→ Common Stock (180,254 underlying)
Footnotes (1)
- [F1]Options vest as follows: 25% of the shares vest on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.
Documents
Issuer
CoLucid Pharmaceuticals, Inc.
CIK 0001348649
Entity typeoperating
Related Parties
1- filerCIK 0001348649
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 12:33 PM ET
- Size
- 5.5 KB